Literature DB >> 29611495

Clinical and Neurophysiological Features of Leprosy Patients with Neuropathic Pain.

Louise Mara Giesel1,2, Izabela Jardim Rodrigues Pitta1,2, Raquel Custódio da Silveira1,2, Lígia Rocha Andrade1,2, Robson Teixeira Vital3,2, José Augusto da Costa Nery2, Mariana de Andrea Vilas Boas Hacker2, Euzenir Nunes Sarno2, Marcia Maria Jardim Rodrigues3,1,2.   

Abstract

Neural pain is a frequent symptom in leprosy disease. There is a paucity of data regarding neural pain diagnostics resulting in common prescriptive errors when neuritis is confused with neuropathic or mixed nociceptive-neuropathic pain. The present study identified important demographic, clinical, and neurophysiological features of 42 leprosy neuropathy patients presenting neuropathic pain (NP). During routine evaluations, patients were selected asking if they had ever experienced neural pain. Data analyses of their pain characteristics, clinical examination results, and both the Douleur Neuropathique 4 Questionnaire and Hamilton Depression Scale scores were used to classify these patients. The most common word they used to describe the sensation of pain for 25 (60%) of these patients was "burning." In the early stages of the disease and before leprosy diagnosis, 19 (45%) had already complained about NP and leprosy treatment was unable to prevent its occurrence in 15 (36%). Leprosy reactions, considered NP risk factors, occurred in 32 (76%) cases. Knowledge of typical NP characteristics could be used to develop more effective therapeutic approaches for a notoriously difficult-to-treat pain condition.

Entities:  

Mesh:

Year:  2018        PMID: 29611495      PMCID: PMC6086157          DOI: 10.4269/ajtmh.17-0817

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  30 in total

1.  Chronic neuropathic pain in treated leprosy.

Authors:  A Hietaharju; R Croft; R Alam; P Birch; A Mong; M Haanpää
Journal:  Lancet       Date:  2000-09-23       Impact factor: 79.321

2.  Incidence of nerve damage in leprosy patients treated with MDT.

Authors:  S Solomon; N Kurian; P Ramadas; P S Rao
Journal:  Int J Lepr Other Mycobact Dis       Date:  1998-12

3.  Aids to the investigation of peripheral nerve injuries. Medical Research Council: Nerve Injuries Research Committee. His Majesty's Stationery Office: 1942; pp. 48 (iii) and 74 figures and 7 diagrams; with aids to the examination of the peripheral nervous system. By Michael O'Brien for the Guarantors of Brain. Saunders Elsevier: 2010; pp. [8] 64 and 94 Figures.

Authors:  Alastair Compston
Journal:  Brain       Date:  2010-10       Impact factor: 13.501

Review 4.  How does Mycobacterium leprae target the peripheral nervous system?

Authors:  A Rambukkana
Journal:  Trends Microbiol       Date:  2000-01       Impact factor: 17.079

Review 5.  NeuPSIG guidelines on neuropathic pain assessment.

Authors:  Maija Haanpää; Nadine Attal; Miroslav Backonja; Ralf Baron; Michael Bennett; Didier Bouhassira; Giorgio Cruccu; Per Hansson; Jennifer A Haythornthwaite; Gian Domenico Iannetti; Troels S Jensen; Timo Kauppila; Turo J Nurmikko; Andew S C Rice; Michael Rowbotham; Jordi Serra; Claudia Sommer; Blair H Smith; Rolf-Detlef Treede
Journal:  Pain       Date:  2010-09-19       Impact factor: 6.961

6.  Studying sex and gender differences in pain and analgesia: a consensus report.

Authors:  Joel D Greenspan; Rebecca M Craft; Linda LeResche; Lars Arendt-Nielsen; Karen J Berkley; Roger B Fillingim; Michael S Gold; Anita Holdcroft; Stefan Lautenbacher; Emeran A Mayer; Jeffrey S Mogil; Anne Z Murphy; Richard J Traub
Journal:  Pain       Date:  2007-10-25       Impact factor: 6.961

7.  Sensitivity and specificity of nerve palpation, monofilament testing and voluntary muscle testing in detecting peripheral nerve abnormality, using nerve conduction studies as gold standard; a study in 357 patients.

Authors:  Fatema Abbas Khambati; Vanaja Prabhakar Shetty; Sunil Dattatraya Ghate; Gospi Dolly Capadia
Journal:  Lepr Rev       Date:  2009-03       Impact factor: 0.537

8.  Prevalence and characteristics of neuropathic pain in leprosy patients treated years ago.

Authors:  José Manuel Ramos; Beatriz Alonso-Castañeda; Dejene Eshetu; Deriba Lemma; Francisco Reyes; Isabel Belinchón; Miguel Górgolas
Journal:  Pathog Glob Health       Date:  2014-06-03       Impact factor: 2.894

9.  Neuropathic pain in leprosy patients.

Authors:  Patrick R N A G Stump; Rosemari Baccarelli; Lúcia H S C Marciano; José R P Lauris; Manoel Jacobsen Teixeira; Somei Ura; Marcos C L Virmond
Journal:  Int J Lepr Other Mycobact Dis       Date:  2004-06

Review 10.  Neuropathic pain: an updated grading system for research and clinical practice.

Authors:  Nanna B Finnerup; Simon Haroutounian; Peter Kamerman; Ralf Baron; David L H Bennett; Didier Bouhassira; Giorgio Cruccu; Roy Freeman; Per Hansson; Turo Nurmikko; Srinivasa N Raja; Andrew S C Rice; Jordi Serra; Blair H Smith; Rolf-Detlef Treede; Troels S Jensen
Journal:  Pain       Date:  2016-08       Impact factor: 7.926

View more
  3 in total

1.  Cytokine Levels in Neural Pain in Leprosy.

Authors:  Débora Bartzen Moraes Angst; Roberta Olmo Pinheiro; Joyce Soares da Silva Vieira; Roberta Arnoldi Cobas; Mariana de Andréa Vilas-Boas Hacker; Izabela Jardim Rodrigues Pitta; Louise Mara Giesel; Euzenir Nunes Sarno; Márcia Rodrigues Jardim
Journal:  Front Immunol       Date:  2020-01-24       Impact factor: 7.561

2.  Assessment of neuropathic pain in leprosy patients with relapse or treatment failure by infrared thermography: A cross-sectional study.

Authors:  Liliane Marques de Pinho Tiago; Diogo Fernandes Dos Santos; Douglas Eulálio Antunes; Letícia Marques Pinho Tiago; Isabela Maria Bernardes Goulart
Journal:  PLoS Negl Trop Dis       Date:  2021-09-23

3.  Ultrasonography as a diagnostic tool for Neural Pain in Leprosy.

Authors:  Clarissa Neves Spitz; Roberto Mogami; Izabela Jardim Rodrigues Pitta; Mariana Andrea Vilas Boas Hacker; Anna Maria Sales; Euzenir Nunes Sarno; Marcia Rodrigues Jardim
Journal:  PLoS Negl Trop Dis       Date:  2022-04-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.